First Presentation of Parkinson Disease Patients to Neurologist

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

NCT00651183 ·Status: COMPLETED

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

NCT02248168 ·Status: COMPLETED

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 ·Status: COMPLETED

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

NCT03710707 ·Status: COMPLETED ·Phase: PHASE1

Apomorphine in Parkinson's Disease Patients With Visual Hallucinations

NCT02702076 ·Status: UNKNOWN ·Phase: PHASE2

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567 ·Status: COMPLETED

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

NCT02373072 ·Status: COMPLETED ·Phase: PHASE1

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

NCT00539214 ·Status: COMPLETED

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

NCT01096186 ·Status: COMPLETED ·Phase: PHASE3

Profile of Depressive Symptoms in Parkinsons Disease

NCT00349310 ·Status: COMPLETED

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

NCT01172379 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)

NCT04185415 ·Status: COMPLETED ·Phase: PHASE1

A Study of NE3107 in Early Parkinson's

NCT06757010 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

NCT02847650 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00368108 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

NCT00304161 ·Status: COMPLETED ·Phase: PHASE4

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

NCT00200525 ·Status: COMPLETED ·Phase: PHASE3

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

NCT04658186 ·Status: COMPLETED ·Phase: PHASE2

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

NCT00148486 ·Status: COMPLETED ·Phase: PHASE2

Mirabegron in Parkinson Disease and Impaired Cognition

NCT02536976 ·Status: COMPLETED ·Phase: PHASE4

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

NCT04056689 ·Status: COMPLETED ·Phase: PHASE1

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

NCT02248207 ·Status: COMPLETED